Global Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Size By Type (Central Dexa Bone Densitometer, Peripheral Dexa Bone Densitometer), By Application (Hospitals, Clinics), By Region, And...

The Global Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 2.2 billion by 2031, growing at a CAGR of 9.1% during the forecast period of 2023–2031. The rising global prevalence of osteoporosis, increasing geriatric population, and growing awareness regarding bone health are key factors driving market growth. DEXA equipment remains a critical diagnostic tool for assessing bone mineral density (BMD) and body composition, with applications expanding in both clinical and research settings.

Drivers:

1. Rising Incidence of Osteoporosis and Related Disorders:

The global increase in osteoporosis and related fractures, especially among postmenopausal women and the elderly, is significantly boosting the demand for accurate diagnostic tools like DEXA.

2. Growing Geriatric Population:

As populations age globally, particularly in countries like Japan, Italy, and Germany, the risk of bone degenerative diseases rises, elevating the demand for DEXA scanning in routine screening.

3. Advancements in Imaging Technology:

Continuous improvements such as faster scanning times, lower radiation doses, and enhanced image clarity have increased the efficiency and safety of DEXA systems, contributing to wider adoption.

Restraints:

1. High Equipment Costs:

The high upfront and maintenance costs of DEXA scanners, especially for smaller hospitals and clinics, can hinder market penetration in developing economies.

2. Limited Reimbursement in Some Regions:

Inadequate insurance coverage and reimbursement policies for bone density scanning in some countries may reduce the accessibility of these services.

Opportunity:

1. Expanding Application in Body Composition Analysis:

Beyond osteoporosis diagnosis, DEXA systems are increasingly used for measuring body fat and lean mass, presenting growth opportunities in sports medicine, obesity research, and general wellness assessments.

2. Untapped Potential in Emerging Markets:

Countries in Asia-Pacific and Latin America are witnessing healthcare infrastructure upgrades, providing a fertile landscape for DEXA equipment expansion due to increasing health awareness and investment.

Market by System Type Insights:

The Central DEXA segment dominated the market in 2023 and is projected to maintain its lead throughout the forecast period. Central DEXA systems, primarily used for hip and spine assessments, are more accurate and preferred in clinical settings. However, Peripheral DEXA systems are gaining traction in outpatient centers and smaller clinics due to their portability and cost-effectiveness.

Market by End-use Insights:

In 2023, the Hospitals and Specialty Clinics segment accounted for the largest revenue share. Hospitals remain the primary adopters of DEXA technology due to their need for advanced diagnostic tools and their role in managing chronic bone conditions. Diagnostic Imaging Centers are expected to witness the fastest growth due to the trend of outsourcing imaging services and rising patient preference for cost-effective outpatient diagnostics.

Market by Regional Insights:

North America led the market in 2023, fueled by a well-established healthcare infrastructure, high prevalence of osteoporosis, and widespread adoption of preventive diagnostics. Asia-Pacific is projected to exhibit the highest growth rate during the forecast period, driven by a growing elderly population, improving healthcare access, and rising awareness of bone health.

Competitive Scenario:

Key players in the DEXA equipment market include Hologic Inc., GE Healthcare, DMS Imaging, OsteoSys Co. Ltd., Medilink, BeamMed Ltd., and Swissray International, Inc. These companies are focusing on R&D investments, regulatory approvals, and geographic expansion. Noteworthy developments include:

2024: Hologic introduced a new DEXA platform with AI integration for improved fracture risk prediction.

2023: GE Healthcare collaborated with sports medicine institutions to expand the use of DEXA in athlete body composition monitoring.

2022: OsteoSys launched a cost-effective peripheral DEXA device targeted at small healthcare centers in Asia.

Scope of Work – Global Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.2 billion

CAGR (2023–2031) 9.1%

Market Segments By System Type (Central, Peripheral), By End-use (Hospitals, Diagnostic Imaging Centers, Others)

Growth Drivers Increasing osteoporosis cases, rising elderly population, and technology